References
- Baggio, S., Deline, S., Studer, J., Mohler-Kuo, M., Daeppen, J.-B., & Gmel, G. (2014). Routes of administration of cannabis used for nonmedical purposes and associations with patterns of drug use. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 54(2), 235–240. https://doi.org/https://doi.org/10.1016/j.jadohealth.2013.08.013
- Borodovsky, J. T., & Budney, A. J. (2018). Cannabis regulatory science: Risk-benefit considerations for mental disorders. International Review of Psychiatry (Abingdon, England), 30(3), 183–202. https://doi.org/https://doi.org/10.1080/09540261.2018.1454406
- Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D., & Bradley, K. A. (1998). The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Archives of Internal Medicine, 158(16), 1789–1795. https://doi.org/https://doi.org/10.1001/archinte.158.16.1789
- CDC - BRFSS. (2020). https://www.cdc.gov/brfss/index.html
- Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda; Board on Population Health and Public Health Practice; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. National Academies Press.
- Compton, W. M., Han, B., Jones, C. M., & Blanco, C. (2019). Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. Drug and Alcohol Dependence, 204, 107468. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2019.05.008
- Dai, H., & Richter, K. P. (2019). A national survey of marijuana use among US adults with medical conditions, 2016-2017. JAMA Network Open, 2(9), e1911936. https://doi.org/https://doi.org/10.1001/jamanetworkopen.2019.11936
- Dave, D., Dench, D., Kenkel, D., Mathios, A., & Wang, H. (2020). News that takes your breath away: Risk perceptions during an outbreak of vaping-related lung injuries. Journal of Risk and Uncertainty, 60(3), 281–307. https://doi.org/https://doi.org/10.1007/s11166-020-09329-2
- Fagerström, K. (2012). Determinants of tobacco use and renaming the FTND to the fagerstrom test for cigarette dependence. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, 14(1), 75–78. https://doi.org/https://doi.org/10.1093/ntr/ntr137
- Goodwin, R. D., Pacek, L. R., Copeland, J., Moeller, S. J., Dierker, L., Weinberger, A., Gbedemah, M., Zvolensky, M. J., Wall, M. M., & Hasin, D. S. (2018). Trends in daily cannabis use among cigarette smokers: United States, 2002-2014. American Journal of Public Health, 108(1), 137–142. https://doi.org/https://doi.org/10.2105/AJPH.2017.304050
- Gorfinkel, L. R., Stohl, M., & Hasin, D. (2020). Association of depression with past-month cannabis use among US adults aged 20 to 59 years, 2005 to 2016. JAMA Network Open, 3(8), e2013802. https://doi.org/https://doi.org/10.1001/jamanetworkopen.2020.13802
- Hasin, D. S. (2018). US epidemiology of cannabis use and associated problems. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 43(1), 195–212. https://doi.org/https://doi.org/10.1038/npp.2017.198
- Hasin, D. S., Sarvet, A. L., Cerdá, M., Keyes, K. M., Stohl, M., Galea, S., & Wall, M. M. (2017). US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013. JAMA Psychiatry, 74(6), 579–588. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2017.0724
- Hurd, Y. L., Spriggs, S., Alishayev, J., Winkel, G., Gurgov, K., Kudrich, C., Oprescu, A. M., & Salsitz, E. (2019). Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: A double-blind randomized placebo-controlled trial. The American Journal of Psychiatry, 176(11), 911–922. https://doi.org/https://doi.org/10.1176/appi.ajp.2019.18101191
- Kalkhoran, S., Levy, D. E., & Rigotti, N. A. (2021). Smoking and vaping among a national sample of U.S. adults during the COVID-19 pandemic. Am J Prev Med. 2022 Mar; 62(3):341–349. doi:https://doi.org/10.1016/j.amepre.2021.08.018
- Keyes, K. M., Wall, M., Feng, T., Cerda, M., & Hasin, D. (2017). Race/ethnicity and marijuana use in the United States: Diminishing differences in the prevalence of use, 2006 to 2015. Drug and Alcohol Dependence, 179, 379–386. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2017.07.027
- King, B. A., Jones, C. M., Baldwin, G. T., & Briss, P. A. (2020). E-cigarette, or vaping, product use-associated lung injury: Looking back, moving forward. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, 22(Suppl 1), S96–S99. https://doi.org/https://doi.org/10.1093/ntr/ntaa186
- Klemperer, E. M., West, J. C., Peasley-Miklus, C., & Villanti, A. C. (2020). Change in tobacco and electronic cigarette use and motivation to quit in response to COVID-19. Nicotine & Tobacco Research, 22(9), 1662–1663. https://doi.org/https://doi.org/10.1093/ntr/ntaa072
- Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B. W., Berry, J. T., & Mokdad, A. H. (2009). The PHQ-8 as a measure of current depression in the general population. Journal of Affective Disorders, 114(1–3), 163–173. https://doi.org/https://doi.org/10.1016/j.jad.2008.06.026
- Lake, S., & St Pierre, M. (2020). The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review. Clinical Psychology Review, 82, 101939. https://doi.org/https://doi.org/10.1016/j.cpr.2020.101939
- Massachusetts Department of Public Health. (2019). Marijuana Baseline Health Study. https://www.mass.gov/doc/marijuana-based-health-study-final-report/download
- Mullins, M. F. (2021). Cannabis dabbing: An emerging trend. Nursing, 51(5), 46–50. https://doi.org/https://doi.org/10.1097/01.NURSE.0000743108.72528.d8
- NCSL. (2021). State medical cannabis laws. Retrieved January 4, 2022, from https://www-ncsl-org.ezp-prod1.hul.harvard.edu/research/health/state-medical-marijuana-laws.aspx
- Pacek, L. R., Malcolm, R. J., & Martins, S. S. (2012). Race/ethnicity differences between alcohol, marijuana, and co-occurring alcohol and marijuana use disorders and their association with public health and social problems using a national sample. The American Journal on Addictions, 21(5), 435–444. https://doi.org/https://doi.org/10.1111/j.1521-0391.2012.00249.x
- Pacek, L. R., Weinberger, A. H., Zhu, J., & Goodwin, R. D. (2020). Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: The role of differentially changing risk perceptions. Addiction (Abingdon, England), 115(5), 935–943. https://doi.org/https://doi.org/10.1111/add.14883
- Parker, M. A., Streck, J. M., Bergeria, C. L., Bunn, J. Y., Galeema, D. E., Davis, D. R., Barrows, A. J., Sigmon, S. C., Tidey, J. W., Heil, S. H., & Higgins, S. T. (2018). Reduced nicotine content cigarettes and cannabis use in vulnerable populations. Tobacco Regulatory Science, 4(5), 84–91. https://doi.org/https://doi.org/10.18001/TRS.4.5.8
- Pearson, J. L., & Villanti, A. C. (2020). It is past time to consider cannabis in vaping research. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, 22(5), 597–598. https://doi.org/https://doi.org/10.1093/ntr/ntaa012
- Russell, C., Rueda, S., Room, R., Tyndall, M., & Fischer, B. (2018). Routes of administration for cannabis use - basic prevalence and related health outcomes: A scoping review and synthesis. The International Journal on Drug Policy, 52, 87–96. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.11.008
- Scavone, J. L., Sterling, R. C., Weinstein, S. P., & Van Bockstaele, E. J. (2013). Impact of cannabis use during stabilization on methadone maintenance treatment. The American Journal on Addictions, 22(4), 344–351. https://doi.org/https://doi.org/10.1111/j.1521-0391.2013.12044.x
- Schauer, G. L., Berg, C. J., Kegler, M. C., Donovan, D. M., & Windle, M. (2015). Assessing the overlap between tobacco and marijuana: Trends in patterns of co-use of tobacco and marijuana in adults from 2003-2012. Addictive Behaviors, 49, 26–32. https://doi.org/https://doi.org/10.1016/j.addbeh.2015.05.012
- Spindle, T. R., Bonn-Miller, M. O., & Vandrey, R. (2019). Changing landscape of cannabis: Novel products, formulations, and methods of administration. Current Opinion in Psychology, 30, 98–102. https://doi.org/https://doi.org/10.1016/j.copsyc.2019.04.002
- Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/https://doi.org/10.1001/archinte.166.10.1092
- Streck, J. M., Kalkhoran, S., Bearnot, B., Gupta, P. S., Kalagher, K. M., Regan, S., Wakeman, S., & Rigotti, N. A. (2021). Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic. Drug and Alcohol Dependence, 218, 108438. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2020.108438
- Suzuki, J., & Weiss, R. D. (2021). Cannabinoids for the treatment of opioid use disorder: Where is the evidence? Journal of Addiction Medicine, 15(2), 91–92. https://doi.org/https://doi.org/10.1097/ADM.0000000000000711
- Wagner, F. A., & Anthony, J. C. (2007). Male-female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol. Drug and Alcohol Dependence, 86(2-3), 191–198. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2006.06.003
- Weinberger, A. H., Zhu, J., Levin, J., Barrington-Trimis, J. L., Copeland, J., Wyka, K., Kim, J. H., & Goodwin, R. D. (2020). Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization. Drug and Alcohol Dependence, 214, 108163. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2020.108163
- Wilkinson, S. T., Yarnell, S., Radhakrishnan, R., Ball, S. A., & D’Souza, D. C. (2016). Marijuana legalization: Impact on physicians and public health. Annual Review of Medicine, 67, 453–466. https://doi.org/https://doi.org/10.1146/annurev-med-050214-013454
- Zielinski, L., Bhatt, M., Sanger, N., Plater, C., Worster, A., Varenbut, M., Daiter, J., Pare, G., Marsh, D. C., Desai, D., MacKillop, J., Steiner, M., McDermid Vaz, S., Thabane, L., & Samaan, Z. (2017). Association between cannabis use and methadone maintenance treatment outcomes: An investigation into sex differences. Biology of Sex Differences, 8, 8. https://doi.org/https://doi.org/10.1186/s13293-017-0130-1